Royalty Pharma PLC reports results for the quarter ended in June - Earnings Summary

Royalty Pharma

08/08/2023 15:58

* Royalty Pharma PLC  RPRX.OQ  reported quarterly adjusted
earnings of 84 cents​​ per share for the quarter ended in June.
The mean expectation of five analysts for the quarter was
for earnings of 81 cents per share.
    * Revenue rose 0.4% to $538.00 million from a year ago;
analysts
expected $536.59 million. 
    * Royalty Pharma PLC's reported EPS for the quarter was 37
cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Royalty Pharma PLC shares had risen by 0.3% this
quarter and
lost 22.0% so far this year.
    * The company reported quarterly net income of $228 million.
    * Wall Street's median 12-month price target for Royalty
Pharma
PLC is $48.80 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 02:58 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.81           0.84           Beat
 Mar. 31 2023      1.27           1.60           Beat
 Dec. 31 2022      1.47           1.56           Beat
 Sep. 30 2022      0.72           0.72           Met